デフォルト表紙
市場調査レポート
商品コード
1621816

dPCRおよびqPCR市場:製品、用途、エンドユーザー別-2025-2030年の世界予測

dPCR & qPCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical Application, Forensic Applications, Research Application), End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
dPCRおよびqPCR市場:製品、用途、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

dPCRおよびqPCR市場は、2023年に80億5,000万米ドルと評価され、2024年には88億8,000万米ドルに達すると予測され、CAGR 10.23%で成長し、2030年には159億4,000万米ドルに達すると予測されています。

デジタルPCR(dPCR)と定量PCR(qPCR)は、DNAやRNAを定量化するために生物学や医学の研究で広く使用されている高度な分子技術です。これらの技術の必要性は、その高精度、高感度、汚染リスクの低減から生じており、臨床診断、遺伝子研究、法医学分析への応用に極めて重要です。これらの技術の最終用途は、医薬品、バイオテクノロジー、農業、環境研究など多様な分野にまたがる一方、病原体検出、遺伝子発現解析、ゲノム研究などの分野でも極めて重要です。市場成長に影響を与える主な促進要因としては、感染症の流行、遺伝性疾患の増加、精密医療の普及などが挙げられます。液滴ベースのdPCRシステムなどの最近の技術的進歩は、ハイスループットと自動処理機能を可能にすることで、大きな潜在機会を提供しています。こうした進歩を活用するため、企業は研究機関との連携を促進し、特定の用途に合わせた使いやすく費用対効果の高いキットの開発に投資すべきです。しかし、機器コストの高さ、データ解釈の複雑さ、潜在的エンドユーザー(特に新興地域)の認知度の低さなどから、市場は限界に直面しています。戦略的な価格設定モデルやしっかりとしたトレーニングプログラムを通じてこれらの課題に対処することで、市場への浸透を拡大できる可能性があります。イノベーションと研究は、治療領域におけるdPCRとqPCRの有用性を拡大するために、リアルタイムのフィールドアプリケーション用のポータブルな統合システムの開発、アッセイの多重化機能の強化、精度と速度の向上に焦点を当てる必要があります。市場はダイナミックであり、主要企業がイノベーションを推進する強力な競合情勢を特徴としています。この市場で成功を収めようとする企業は、戦略的提携を優先し、次世代技術による製品ポートフォリオの拡充に注力し、新たな規制や標準に積極的に対応することで、自社のソリューションがライフサイエンスや農業分野の進化するニーズに確実に応えられるようにする必要があります。

主な市場の統計
基準年[2023] 80億5,000万米ドル
推定年[2024] 88億8,000万米ドル
予測年[2030] 159億4,000万米ドル
CAGR(%) 10.23%

市場力学:急速に進化するdPCRおよびqPCR市場の主要市場インサイトを公開

dPCRおよびqPCR市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 感染症および遺伝性疾患の有病率の上昇
    • 個別化医療を効率的に提供するためのdPCRとqPCRの利用増加
    • 安全性と消費を確保するための食品検査手順における採用の増加
  • 市場抑制要因
    • dPCRおよびqPCRに関連する高コスト
  • 市場機会
    • PCR技術の技術的進歩
    • 世界のゲノミクス研究プロジェクトへの資金提供の増加
  • 市場の課題
    • dPCRおよびqPCR技術に伴う技術的限界とデータ解析の複雑さ

ポーターのファイブフォース:dPCRおよびqPCR市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:dPCRおよびqPCR市場における外部からの影響の把握

外部マクロ環境要因は、dPCRおよびqPCR市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析dPCRおよびqPCR市場における競合情勢の把握

dPCRおよびqPCR市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスdPCRおよびqPCR市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、dPCRおよびqPCR市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨dPCRおよびqPCR市場における成功への道筋を描く

dPCRおよびqPCR市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 感染症や遺伝性疾患の蔓延
      • 個別化医療の効率的な提供のためのdPCRとqPCRの使用の増加
      • 食品の安全性と消費を確保するための食品検査手順の採用の改善
    • 抑制要因
      • dPCRとqPCRに関連する高コスト
    • 機会
      • PCR技術の技術的進歩
      • 世界中でゲノム調査プロジェクトへの資金提供が増加
    • 課題
      • dPCRおよびqPCR技術に関連する技術的制限とデータ分析の複雑さ
  • 市場セグメンテーション分析
    • 製品:遺伝子配列を迅速に検出する高度なPCR機器の普及
    • アプリケーション:感染モニタリングと検出のための臨床アプリケーションにおけるdPCRとqPCRの利用
    • エンドユーザー:PCR技術に対する学術調査と学術機関の注目の高まり
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 dPCRおよびqPCR市場:製品別

  • 機器
  • 試薬・消耗品
  • ソフトウェアとサービス

第7章 dPCRおよびqPCR市場:用途別

  • 臨床応用
    • 血液検査
    • 腫瘍学検査
    • 病原体検査
  • 法医学アプリケーション
  • 調査アプリケーション

第8章 dPCRおよびqPCR市場:エンドユーザー別

  • 学術調査機関
  • 契約調査機関
  • 病院と介護サービス提供者
  • 製薬・バイオテクノロジー企業

第9章 南北アメリカのdPCRおよびqPCR市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のdPCRおよびqPCR市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのdPCRおよびqPCR市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • QIAGEN、バイオ医薬品業界向けデジタルPCRキットとサービスのラインアップを拡大
    • Virax Biolabs Group LimitedはマールブルグウイルスPCR検査キットの配布契約を締結しました
    • サーモフィッシャーサイエンティフィック、新しいデジタルPCR自動化ソリューションを発表
  • 戦略分析と提言

企業一覧

  • 10x Genomics, Inc.
  • Abbott Laboratories
  • accela s.r.o.
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMed Central Ltd
  • BioMerieux S.A.
  • Canopy Biosciences, LLC
  • Combinati Inc.
  • Danaher Corporation
  • F. Hoffman-La Roche Ltd.
  • GE Healthcare Inc.
  • JN Medsys Pte. Ltd.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Pfizer Inc.
  • Promega Corporation
  • QIAGEN N.V. by Thermo Fisher Scientific, Inc.
  • Roche Holding AG
  • Siemens Healthineers AG
  • Stilla Technologies SA
  • Takara Bio Inc.
  • Vela Diagnostics
図表

LIST OF FIGURES

  • FIGURE 1. DPCR & QPCR MARKET RESEARCH PROCESS
  • FIGURE 2. DPCR & QPCR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DPCR & QPCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DPCR & QPCR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DPCR & QPCR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DPCR & QPCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DPCR & QPCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DPCR & QPCR MARKET DYNAMICS
  • TABLE 7. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DPCR & QPCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DPCR & QPCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DPCR & QPCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DPCR & QPCR MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DPCR & QPCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DPCR & QPCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DPCR & QPCR MARKET SIZE, BY FORENSIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DPCR & QPCR MARKET SIZE, BY RESEARCH APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DPCR & QPCR MARKET SIZE, BY ACADEMIC RESEARCH & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DPCR & QPCR MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DPCR & QPCR MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DPCR & QPCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. DPCR & QPCR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. DPCR & QPCR MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-430D3EB720F1

The dPCR & qPCR Market was valued at USD 8.05 billion in 2023, expected to reach USD 8.88 billion in 2024, and is projected to grow at a CAGR of 10.23%, to USD 15.94 billion by 2030.

Digital PCR (dPCR) and quantitative PCR (qPCR) are advanced molecular technologies used extensively in biological and medical research for quantifying DNA and RNA. The necessity for these technologies arises from their high precision, sensitivity, and reduction in risk of contamination, crucial for applications in clinical diagnostics, genetic research, and forensic analysis. The end-use scope of these technologies spans across diverse sectors including pharmaceuticals, biotechnology, agriculture, and environmental studies, whilst being pivotal in areas such as pathogen detection, gene expression analysis, and genomic studies. Key drivers influencing market growth include the increasing prevalence of infectious diseases, rising incidences of genetic disorders, and widespread adoption of precision medicine. Recent technological advancements, such as droplet-based dPCR systems, offer significant potential opportunities by enabling high-throughput and automated processing capabilities. To capitalize on these advancements, businesses should foster collaborations with research institutions and invest in developing user-friendly, cost-effective kits tailored for specific applications. However, the market faces limitations due to high equipment costs, complexity in data interpretation, and limited awareness among potential end-users, particularly in emerging regions. Addressing these challenges through strategic pricing models and robust training programs could expand market penetration. Innovation and research should focus on developing portable, integrated systems for real-time field applications, enhancing assay multiplexing capabilities, and improving accuracy and speed to broaden the utility of dPCR and qPCR in therapeutic areas. The market is dynamic, characterized by a strong competitive landscape with key players driving innovation. Firms looking to thrive in this market should prioritize strategic alliances, focus on expanding their product portfolio with next-gen technologies, and proactively adapt to emerging regulations and standards to ensure their solutions meet the evolving needs of the life sciences and agricultural sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 8.05 billion
Estimated Year [2024] USD 8.88 billion
Forecast Year [2030] USD 15.94 billion
CAGR (%) 10.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving dPCR & qPCR Market

The dPCR & qPCR Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of infectious diseases and genetic disorders
    • Increasing usage of dPCR and qPCR for efficient delivery of personalized medicine
    • Improving adoption in food testing procedures to ensure safety and consumption
  • Market Restraints
    • High cost associated with dPCR and qPCR
  • Market Opportunities
    • Technological advancements in PCR technologies
    • Growing funding for genomics research projects worldwide
  • Market Challenges
    • Technical limitations and data analysis complexities associated with dPCR and qPCR techniques

Porter's Five Forces: A Strategic Tool for Navigating the dPCR & qPCR Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the dPCR & qPCR Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the dPCR & qPCR Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the dPCR & qPCR Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the dPCR & qPCR Market

A detailed market share analysis in the dPCR & qPCR Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the dPCR & qPCR Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the dPCR & qPCR Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the dPCR & qPCR Market

A strategic analysis of the dPCR & qPCR Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the dPCR & qPCR Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Abbott Laboratories, accela s.r.o., Agilent Technologies, Inc., Analytik Jena GmbH, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., BioMed Central Ltd, BioMerieux S.A., Canopy Biosciences, LLC, Combinati Inc., Danaher Corporation, F. Hoffman-La Roche Ltd., GE Healthcare Inc., JN Medsys Pte. Ltd., Merck KGaA, PerkinElmer, Inc., Pfizer Inc., Promega Corporation, QIAGEN N.V. by Thermo Fisher Scientific, Inc., Roche Holding AG, Siemens Healthineers AG, Stilla Technologies SA, Takara Bio Inc., and Vela Diagnostics.

Market Segmentation & Coverage

This research report categorizes the dPCR & qPCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Application, market is studied across Clinical Application, Forensic Applications, and Research Application. The Clinical Application is further studied across Blood Screening, Oncology Testing, and Pathogen Testing.
  • Based on End-User, market is studied across Academic Research & Institutes, Contract Research Organizations, Hospitals & Care Providers, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of infectious diseases and genetic disorders
      • 5.1.1.2. Increasing usage of dPCR and qPCR for efficient delivery of personalized medicine
      • 5.1.1.3. Improving adoption in food testing procedures to ensure safety and consumption
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with dPCR and qPCR
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in PCR technologies
      • 5.1.3.2. Growing funding for genomics research projects worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and data analysis complexities associated with dPCR and qPCR techniques
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding presence of sophisticated PCR instruments for rapid detection of genetic sequences
    • 5.2.2. Application: Utilization of dPCR and qPCR in clinical applications for infection monitoring and detection
    • 5.2.3. End-user: Rising focus of academic research and academic institutes toward PCR technologies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. dPCR & qPCR Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. dPCR & qPCR Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical Application
    • 7.2.1. Blood Screening
    • 7.2.2. Oncology Testing
    • 7.2.3. Pathogen Testing
  • 7.3. Forensic Applications
  • 7.4. Research Application

8. dPCR & qPCR Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Research & Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Hospitals & Care Providers
  • 8.5. Pharmaceutical & Biotechnology Companies

9. Americas dPCR & qPCR Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific dPCR & qPCR Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa dPCR & qPCR Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. QIAGEN Expands Range of Digital PCR Kits and Services for the Biopharma Industry
    • 12.3.2. Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
    • 12.3.3. Thermo Fisher Scientific Launches New Digital PCR Automation Solution
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Abbott Laboratories
  • 3. accela s.r.o.
  • 4. Agilent Technologies, Inc.
  • 5. Analytik Jena GmbH
  • 6. Becton Dickinson and Company
  • 7. Bio-Rad Laboratories, Inc.
  • 8. BioMed Central Ltd
  • 9. BioMerieux S.A.
  • 10. Canopy Biosciences, LLC
  • 11. Combinati Inc.
  • 12. Danaher Corporation
  • 13. F. Hoffman-La Roche Ltd.
  • 14. GE Healthcare Inc.
  • 15. JN Medsys Pte. Ltd.
  • 16. Merck KGaA
  • 17. PerkinElmer, Inc.
  • 18. Pfizer Inc.
  • 19. Promega Corporation
  • 20. QIAGEN N.V. by Thermo Fisher Scientific, Inc.
  • 21. Roche Holding AG
  • 22. Siemens Healthineers AG
  • 23. Stilla Technologies SA
  • 24. Takara Bio Inc.
  • 25. Vela Diagnostics